Fatty acid desaturase 1 gene polymorphisms control human hepatic lipid composition

Fatty acid desaturase (FADS) genes and their variants have been associated with multiple metabolic phenotypes, including liver enzymes and hepatic fat accumulation, but the detailed mechanism remains unclear. We aimed to delineate the role of FADSs in modulating lipid composition in human liver. We performed a targeted lipidomic analysis of a variety of phospholipids, sphingolipids, and ceramides among 154 human liver tissue samples. The associations between previously genome‐wide association studies (GWASs)‐identified six FADS single‐nucleotide polymorphisms (SNPs), and these lipid levels as well as total hepatic fat content (HFC) were tested. The potential function of these SNPs in regulating transcription of three FADS genes (FADS1, FADS2, and FADS3) in the locus was also investigated. We found that though these SNPs were in high linkage disequilibrium (r2 > 0.8), the rare alleles of these SNPs were consistently and significantly associated with the accumulation of multiple long‐chain fatty acids (LCFAs), with C47H85O13P (C36:4), a phosphatidylinositol (PI), and C43H80O8PN (C38:3), a phosphatidylethanolamine (PE), reached the Bonferroni corrected significance (P < 3 × 10−4). Meanwhile, these SNPs were significantly associated with increased ratios between the more saturated and relatively less saturated forms of LCFAs, especially between PEs, PIs, and phosphatidylcholines (PCs; P ≤ 3.5 × 10−6). These alleles were also associated with increased total HFC (P < 0.05). Further analyses revealed that these alleles were associated with decreased hepatic expression of FADS1 (P = 0.0018 for rs174556), but not FADS2 or FADS3 (P > 0.05). Conclusion: Our findings revealed critical insight into the mechanism underlying FADS1 and its polymorphisms in modulating hepatic lipid deposition by altering gene transcription and controlling lipid composition in human livers. (Hepatology 2015;61:119–128)

[1]  G. Bedogni,et al.  Docosahexaenoic acid supplementation decreases liver fat content in children with non-alcoholic fatty liver disease: double-blind randomised controlled clinical trial , 2011, Archives of Disease in Childhood.

[2]  Thomas Illig,et al.  SNPs of the FADS Gene Cluster are Associated with Polyunsaturated Fatty Acids in a Cohort of Patients with Cardiovascular Disease , 2008, Lipids.

[3]  H. Stöhr,et al.  cDNA cloning, genomic structure, and chromosomal localization of three members of the human fatty acid desaturase family. , 2000, Genomics.

[4]  M. Taskinen,et al.  A gene variant of PNPLA3, but not of APOC3, is associated with histological parameters of NAFLD in an obese population , 2013, Obesity.

[5]  D. Mutch,et al.  Genetic variation in lipid desaturases and its impact on the development of human disease , 2010, Lipids in Health and Disease.

[6]  A. Simopoulos.  Artemis P Simopoulos of nutritional requirements and chronic disease risk Genetic variants in the metabolism of omega-6 and omega-3 fatty acids : their role in the determination , 2010 .

[7]  S. Sasaki,et al.  Lower estimates of delta-5 desaturase and elongase activity are related to adverse profiles for several metabolic risk factors in young Japanese women. , 2008, Nutrition research.

[8]  Luigi Ferrucci,et al.  Genome-Wide Association Study of Plasma Polyunsaturated Fatty Acids in the InCHIANTI Study , 2009, PLoS genetics.

[9]  G. Bedogni,et al.  Prolonged n‐3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non‐alcoholic fatty liver disease: a pilot study , 2006, Alimentary pharmacology & therapeutics.

[10]  T. Illig,et al.  Do FADS genotypes enhance our knowledge about fatty acid related phenotypes? , 2010, Clinical nutrition.

[11]  Manabu T. Nakamura,et al.  STRUCTURE, FUNCTION, AND DIETARY REGULATION OF Δ6, Δ5, AND Δ9 DESATURASES , 2004 .

[12]  Christian Gieger,et al.  Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma , 2011, Nature Genetics.

[13]  Yurii S. Aulchenko,et al.  Genome-Wide Association Study Identifies Novel Loci Associated with Circulating Phospho- and Sphingolipid Concentrations , 2012, PLoS genetics.

[14]  E. Taylor,et al.  Association of Fatty Acid Desaturase Genes with Attention-Deficit/Hyperactivity Disorder , 2006, Biological Psychiatry.

[15]  Shengying Qin,et al.  Mapping of hepatic expression quantitative trait loci (eQTLs) in a Han Chinese population , 2014, Journal of Medical Genetics.

[16]  Alexander Pertsemlidis,et al.  Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease , 2008, Nature Genetics.

[17]  M. Olivier,et al.  Interactions of allelic variance of PNPLA3 with nongenetic factors in predicting nonalcoholic steatohepatitis and nonhepatic complications of severe obesity , 2013, Obesity.

[18]  M. Fornage,et al.  Genetic Loci Associated with Plasma Phospholipid n-3 Fatty Acids: A Meta-Analysis of Genome-Wide Association Studies from the CHARGE Consortium , 2011, PLoS genetics.

[19]  J. Ramírez,et al.  SNPs affecting serum metabolomic traits may regulate gene transcription and lipid accumulation in the liver. , 2012, Metabolism: clinical and experimental.

[20]  A. Sanyal.  NASH: A global health problem , 2011, Hepatology research : the official journal of the Japan Society of Hepatology.

[21]  P. Koulen,et al.  Lipid Profiling Reveals Tissue-Specific Differences for Ethanolamide Lipids in Mice Lacking Fatty Acid Amide Hydrolase , 2010, Lipids.

[22]  U. Das.  A defect in the activity of Delta6 and Delta5 desaturases may be a factor in the initiation and progression of atherosclerosis. , 2007, Prostaglandins, leukotrienes, and essential fatty acids.

[23]  Christian Gieger,et al.  Genetics Meets Metabolomics: A Genome-Wide Association Study of Metabolite Profiles in Human Serum , 2008, PLoS genetics.

[24]  U. Das.  A defect in the activity of Δ6 and Δ5 desaturases may be a factor in the initiation and progression of atherosclerosis , 2007 .

[25]  G. Davey Smith,et al.  FADS2 Polymorphisms Modify the Effect of Breastfeeding on Child IQ , 2010, PloS one.

[26]  T. Yanagita,et al.  Dietary phosphatidylinositol prevents the development of nonalcoholic fatty liver disease in Zucker (fa/fa) rats. , 2008, Journal of agricultural and food chemistry.

[27]  A. Mazur,et al.  Omega-3 fatty acids for treatment of non-alcoholic fatty liver disease: design and rationale of randomized controlled trial , 2013, BMC Pediatrics.

[28]  S. Rapoport,et al.  Quantitative contributions of diet and liver synthesis to docosahexaenoic acid homeostasis. , 2010, Prostaglandins, leukotrienes, and essential fatty acids.

[29]  C. Hoggart,et al.  Genome-wide association analysis of metabolic traits in a birth cohort from a founder population , 2008, Nature Genetics.

[30]  Yanfang Jiang,et al.  A Case-Control Study between Gene Polymorphisms of Polyunsaturated Fatty Acid Metabolic Rate-Limiting Enzymes and Acute Coronary Syndrome in Chinese Han Population , 2013, BioMed research international.

[31]  Thomas Illig,et al.  FADS genotypes and desaturase activity estimated by the ratio of arachidonic acid to linoleic acid are associated with inflammation and coronary artery disease. , 2008, The American journal of clinical nutrition.

[32]  Christopher D. Brown,et al.  Identification, Replication, and Functional Fine-Mapping of Expression Quantitative Trait Loci in Primary Human Liver Tissue , 2011, PLoS genetics.

[33]  A. Caspi,et al.  Moderation of breastfeeding effects on the IQ by genetic variation in fatty acid metabolism , 2007, Proceedings of the National Academy of Sciences.

[34]  L. Palmer,et al.  Common genetic variants of the FADS1 FADS2 gene cluster and their reconstructed haplotypes are associated with the fatty acid composition in phospholipids. , 2006, Human molecular genetics.

[35]  Manabu T. Nakamura,et al.  Structure, function, and dietary regulation of delta6, delta5, and delta9 desaturases. , 2004, Annual review of nutrition.

[36]  John Hart,et al.  Comparing morphometric, biochemical, and visual measurements of macrovesicular steatosis of liver. , 2011, Human pathology.

[37]  M. Sherman,et al.  Nutritional assessment and hepatic fatty acid composition in non-alcoholic fatty liver disease (NAFLD): a cross-sectional study. , 2008, Journal of hepatology.

[38]  D. Postma,et al.  Variants of the FADS1 FADS2 Gene Cluster, Blood Levels of Polyunsaturated Fatty Acids and Eczema in Children within the First 2 Years of Life , 2010, PloS one.

[39]  S. Innis,et al.  Genetic variants of the FADS1 FADS2 gene cluster are associated with altered (n-6) and (n-3) essential fatty acids in plasma and erythrocyte phospholipids in women during pregnancy and in breast milk during lactation. , 2008, The Journal of nutrition.

[40]  R. Rodrigo,et al.  Decreased Liver Fatty Acid Δ‐6 and Δ‐5 Desaturase Activity in Obese Patients , 2010, Obesity.

[41]  Christian Gieger,et al.  A genome-wide perspective of genetic variation in human metabolism , 2010, Nature Genetics.

[42]  P. Kraft,et al.  Does genetic variation in the Delta6-desaturase promoter modify the association between alpha-linolenic acid and the prevalence of metabolic syndrome? , 2009, The American journal of clinical nutrition.

[43]  M. Zeegers,et al.  FADS1 FADS2 gene variants modify the association between fish intake and the docosahexaenoic acid proportions in human milk. , 2010, The American journal of clinical nutrition.

[44]  J. Heinrich,et al.  Role of FADS1 and FADS2 polymorphisms in polyunsaturated fatty acid metabolism. , 2010, Metabolism: clinical and experimental.

[45]  S. Piro,et al.  Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease. , 2008, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[46]  Berthold Koletzko,et al.  Genetic variants of the FADS1 FADS2 gene cluster as related to essential fatty acid metabolism , 2010, Current opinion in lipidology.